- Home
- RLAY vs MUX Comparison
RLAY vs MUX Comparison
Compare RLAY & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- MUX
- Stock Information
- Founded
- RLAY 2015
- MUX 1979
- Country
- RLAY United States
- MUX Canada
- Employees
- RLAY N/A
- MUX N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- MUX Precious Metals
- Sector
- RLAY Health Care
- MUX Basic Materials
- Exchange
- RLAY Nasdaq
- MUX Nasdaq
- Market Cap
- RLAY 576.1M
- MUX 524.8M
- IPO Year
- RLAY 2020
- MUX N/A
- Fundamental
- Price
- RLAY $3.63
- MUX $11.42
- Analyst Decision
- RLAY Strong Buy
- MUX Strong Buy
- Analyst Count
- RLAY 11
- MUX 2
- Target Price
- RLAY $18.40
- MUX $15.25
- AVG Volume (30 Days)
- RLAY 1.6M
- MUX 924.4K
- Earning Date
- RLAY 08-05-2025
- MUX 08-06-2025
- Dividend Yield
- RLAY N/A
- MUX N/A
- EPS Growth
- RLAY N/A
- MUX N/A
- EPS
- RLAY N/A
- MUX N/A
- Revenue
- RLAY $7,679,000.00
- MUX $168,945,000.00
- Revenue This Year
- RLAY $14.31
- MUX N/A
- Revenue Next Year
- RLAY N/A
- MUX $0.31
- P/E Ratio
- RLAY N/A
- MUX N/A
- Revenue Growth
- RLAY N/A
- MUX N/A
- 52 Week Low
- RLAY $1.78
- MUX $6.38
- 52 Week High
- RLAY $10.72
- MUX $11.46
- Technical
- Relative Strength Index (RSI)
- RLAY 63.22
- MUX 76.46
- Support Level
- RLAY $3.10
- MUX $9.25
- Resistance Level
- RLAY $3.75
- MUX $11.24
- Average True Range (ATR)
- RLAY 0.23
- MUX 0.43
- MACD
- RLAY 0.03
- MUX 0.15
- Stochastic Oscillator
- RLAY 84.42
- MUX 100.00
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company primarily generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, most production occurs in the United States.